Degeneration of the rod and cone photoreceptors in the human retina is among the most common causes of blindness. Replacing these damaged photoreceptors may help to restore vision.
Background

Retina Structure and Diseases
The vertebrate retina is composed of multiple cells types, including rod and cone photoreceptors, the retinal pigmented epithelium, ganglion and amacrine cells. These cells organize into layers to form the neural retina (Figure 1) . Degenerations of the rod and cone photoreceptors in the human retina are a major cause of blindness and affect millions of people in the United States. Age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are two of the leading causes of blindness in adults. Both diseases involve the loss of the light sensitive rod and cone cells that line the retina, causing decreased sensitivity to light, and the progressive loss of vision. One of the main issues regarding blindness is that most people do not notice any vision impairment until roughly 90% of their photoreceptors have degenerated. There are currently no treatments to halt or delay the onset and progression of these diseases. However, the replacement of photoreceptors through transplantation into the retina has been shown to restore light sensitivity in mice (Lamba et al., 2009) , and represents a possible form of treatment. The generation of iPS cells allows for different cell lines to be redirected into undifferentiated cells, and then differentiated into various cell types (Takahashi and Yamanaka, 2006) . Several groups have shown that these iPS cells can be used to study specific diseases (Dimos et al., 2008) . By taking a lymphocyte from a patient with a disease of interest, and a person without the disease, undifferentiated iPS cells can be grown from each, and differentiated into the cell type impacted by the disease. This can be useful to study disease progression, and to compare the gene expression levels photoreceptors derived from the two individuals over time, to gain an understanding of the underlying cause of the disease. This technique can be useful to study the development and maturation of photoreceptors derived from patients with either AMD of RP.
One possible treatment for retinal degenerative disorders is cell replacement therapy.
Differentiation of either hES cells and iPS cells into retinal progenitors allows these cells to be expanded and matured to become photoreceptors, (Lamba et al., 2009) . Previous studies have shown that mice and human photoreceptors can integrate into the retina of adult mice and even restore function (Lamba et al., 2009; MacLaren et al., 2006) . However, the rate of successful integration of these cells is relatively low. Additionally, the transplanted photoreceptors are susceptible to the same degenerations as the native cells. This issue places great importance of higher rates of integration, as well as creating mature and functional photoreceptors en masse for sequential transplantations. Stem cells provide a self-renewing source of cells that can be differentiated on a large enough scale to provide this method of cell replacement.
Creating photoreceptors from pluripotent stem cells requires a specific protocol in order to properly induce retinal differentiation. Proper forebrain development of the nervous system relies on two critical signaling pathways: the BMP and Wnt pathways (Niehrs, 2001 ). More specifically, induction of retinal cells through recombinant proteins can be achieved by creating low levels of BMP and Wnt signaling (del Barco Barrantes et al., 2003) . Dickkopf-1 (Dkk1) and Noggin have been shown to inhibit Wnt and BMP signaling, respectively. Although the precise mechanism of these genes is currently unknown, inhibition of Dkk1 and Noggin in mice embryos leads to a lack of eyes and other abnormalities in head development. In addition, Insulin-like growth factor 1 (IGF1) has been shown to promote eye induction (Pera et al., 2001 ).
Wnt signaling is associated with development of the spinal cord, midbrain and hindbrain (Castelo-Branco et al., 2003; McMahon and Bradley, 1990) . In contrast, inhibition of Wnt activity during this period of embryonic development is associated with forebrain induction (Mukhopadhyay et al., 2001; Sanges et al., 2013) . Several studies have shown that the inhibition of the BMP pathway in the embryo pushes developing cells towards a neural fate (HemmatiBrivanlou et al., 1994; Lamb et al., 1993; Smith et al., 1993) .
Inhibition of these pathways requires recombinant proteins. However, recombinant proteins are relatively expensive and slow acting in vitro. The use of small molecule inhibitors of these pathways at precise stages helps to push for specific differentiation (Nelson et al., 2007) and would allow more precise control of the cell types formed during differentiation. The progression of retinal and photoreceptor differentiation can be tracked looking at expression levels of several different genes including eye field transcription factors (EFTFs) such as Pax6, Six2, Lhx2 and Rx as well as photoreceptor specific genes such as Crx, Blimp1, and Recoverin.
These genes are upregulated during the early stages of differentiation and can be used to investigate whether the stem cells are taking on the desired cell fate (Lamba et al., 2006) . 
Formation of Optic Cups
In order to quickly influence the maturation of the neural stem cells into photoreceptors, these neural progenitor cells can be cultured in floating low-attachment conditions. In a three dimensional structure, the neural retina can self-organize into optic cup structures (Nakano et al., 2012) . These hES derived cells organized into a layered structure, with the light sensitive rod and cone cells lining the outer ring of the spherical cell clusters. Neural spheres, such as these, mimic the natural organization and structure of the developing eye in vivo. A key feature of these floating optic cups is the short time they take to form. Within days, the neural progenitor cells begin to self-organize. Therefore, a three-dimensional cell culture can enhance differentiation and maturation of these cells, allowing a more efficient method of preparing these cells for transplantation.
Diabetic Retinopathy
Damage to the retina due to complications of diabetes is a rising concern. Diabetic Retinopathy (DR) is the leading cause of blindness in people ages 20-64, and accounts for roughly 12% of new cases of blindness per year (Engelgau et al., 2004) . Furthermore, 25% of diabetic patients reported visual impairments, which is twice the proportion compared to individuals without diabetes (Saaddine et al., 1999) . DR is characterized by an increase of the permeability in the capillaries and other small vessels in the eye (Singh et al., 2009 ). While AMD is the leading cause of blindness among the elderly, DR is predicted to be the leading cause of blindness among the younger, population (Aiello, 2003; Moss et al., 1998) .
Patients of both type 1 and type 2 diabetes are susceptible to DR. Considering cases with disease duration over twenty years, 95% of patients with type 1 diabetes have DR, while 60% of type 2 diabetic patients have DR (Sayin et al., 2015) . Hyperglycemia plays an important role in DR by causing vascular endothelial dysfunction (Matthews et al., 2004) , although the precise mechanism of action is largely unknown. One proposed factor for the negative effects of DR is chronic oxidative stress (Baynes, 1991; Cui et al., 2006; Kowluru et al., 2001; Zong et al., 2011) .
Methylglyoxal (MG) has been tested as a source of oxidative stress (Shipanova et al., 1997 ) and leads to the accumulation of advanced glycation end products (AGEs), which are implicated with retinal complications (Kyselova et al., 2004) . Accumulation of AGEs leads to apoptosis in retinal cells (Denis et al., 2002) . MG has been shown to cause accumulation of AGEs and increases apoptosis of many cell types found in the eye both in vitro and in vivo (Kim et al., 2012) . (Table 1) . Photoreceptors derived from undifferentiated cells from a healthy patient as well as a family member with RP are used in order to determine any differences in the maturation process. Theoretically, genetic differences between these family members may be linked to the disease itself. Since these are degenerative diseases, having photoreceptors derived from these individuals can allow us to compare the formation and maturation of these photoreceptors over a long period of time.
Aim 2:
Model retinal degenerations such as those associated with Diabetic Retinopathy using photoreceptors derived from human induced pluripotent stem cells Access to human cells through stem cell technologies allows us unprecedented ability to directly study human development and degenerations. Here, we study the effects of diabetes on the human retina. Using Methylglyoxal (MG), a chief metabolite that accumulates in tissues in diabetes, we explore the disease development, in vitro, in human stem-cell derived retinal cultures.
Materials and Methods
Creation of Induced Pluripotent Cells from Human Lymphocytes
Lymphocytes from both healthy and diseased patients were obtained (Coriell Biorepository, Camden, NJ) and an iPS cell line was made as previously described (Okita et al., 2011) . iPS cells were made from a patient with RP, as well as an unaffected cousin to serve as the control. Briefly, fibroblast cultures were electroporated with episomal plasmid vectors. Following 48 hours of electroporation, the media was changed to hES media, consisting of DME/F-12 1:1 (HyClone Logan, UT) with 20% Knockout Serum Replacement (KSR; Gibco, Grand Island, NY), confluence, generally after 4-5 days of growth. Cells were passaged by an initial wash with 1x PBS (Corning), followed by the addition of a 1 mM solution of sodium citrate (Sigma Aldrich).
Sodium citrate was aspirated off after 5 minutes and cells were removed by manually scraping the cells with a 200 uL disposable pipette tip (BioExpress, Kaysville, UT) in the presence of Essential 8 medium. The cell suspension from a single well was collected and directly passaged onto all 6 wells of a 6 well plate for a 1:6 passaging ratio.
Stem Cell Differentiation into Retinal Stem Cells
The iPS cells were differentiated into Neural Stem Cells (NSC) by adding differentiation media consisting of DME/F-12 1:1 (HyClone) with 10% Knockout Serum Replacement (KSR; Gibco), 1% Penicillin Streptomycin Amphotericin B (Lonza), 1% Sodium pyruvate (Corning), 1% Sodium Bicarbonate (Corning), 1% HEPES Buffer (Corning), and 1% MEM Nonessential Amino Acids (Corning) (Anchan et al., 1991) . Following filtration in a 500 mL vacuum-driven filter system (Argos), 5 mL of N1 Media Supplement (Sigma Aldrich) was added (Price et al., 2002) . Finally, we added the small molecules IWR1 (Sigma Aldrich), SB431542 (Stemgent), LDN193189 (Stemgent) and the recombinant protein IGF1 (R&D Systems). Cells were allowed to grow in this medium with daily changes for 5 days. On the fifth day, cells were passaged by washing the cells once with PBS (Corning), adding 1 mL of Accutase (Global Cell Solutions, Charlottesville, VA) and letting the Accutase sit for 5 minutes. Then,, the Accutase was aspirated, and the cells were washed twice with PBS. Next, 2 mL of PBS was added and cells were manually scraped off the plate using a 200 uL disposable pipette tip (BioExpress). The cell suspension was centrifuged for three minutes at 1500 rpm at room temperature. The supernatant was aspirated off and the cell pellet was resuspended in NSC media, and re-plated onto 2 wells of a 6 well plate, for a passaging ratio of 1:2. NSC media is comprised of DME/F-12 1:1 (HyClone), 0.5% Fetal Bovine Serum (FBS, Atlanta Biologicals), 1% Penicillin Streptomycin Amphotericin B (Lonza), 1% Sodium pyruvate (Corning), 1% Sodium Bicarbonate (Corning), 1% HEPES Buffer (Corning), and 1% MEM Nonessential Amino Acids (Corning). Following filtration in a 500 mL vacuum-driven filter system (Argos), 5 mL of N1 Media Supplement (Sigma Aldrich) was added. Cells were cultured in this media indefinitely. In order to grow the neural progenitor cells as a floating, three dimensional culture, clusters were removed from the Matrigel coated plate by manually removing the areas of interest with a 200 uL pipette tip (BioExpress). Selected clusters were moved into an Ultra-Low Attachment Plate (Corning), and were allowed to grow floating in 2 mL of NSC media. Media was added twice a week until a volume of 5 mL was reached in the floating well, at which point the media containing the cells was collected and the cell cultures were allowed to aggregate at the bottom of a 15 mL centrifuge tube. Spent media was aspirated, and cells were replenished with 2 mL fresh media and returned to the low attachment plate.
Retinal Pigment Epithelium
Retinal Pigment Epithelium (RPE) cells were cultured similarly to the neural cells. The differentiation steps and initial passaging were carried out identically. After passaging, any cells displaying the morphology typical of RPE cells, including hexagonal shape and any pigmentation, are manually separated from the neural cells (Figure 3) . Using a 200 uL pipette tip, any region showing RPE morphology was removed, and centrifuged as described above. The supernatant is aspirated, and the cells are resuspended in RPE media. A 6 well plate of differentiated cells can be combined to fill one well of a six well plate of newly picked RPE cells. A 500 mL bottle of RPE media consists of DME/F-12 1:1 (HyClone), 5% Fetal Bovine Serum (FBS; Atlanta Biologicals), 1% Penicillin Streptomycin Amphotericin B (Lonza), 1% Sodium pyruvate (Corning), 1% GLUTAMAX (Gibco), 125 mg Taurine (Sigma Aldrich), 10 ug Hydrocortisone (Sigma Aldrich) and .0065 ug Triiodo-thyronin (Sigma Aldrich). Once the cells became confluent, the FBS was reduced to 1%. After filtration in a 50 mL vacuum-driven filter system (Argos, Logan, UT), 5 mL of N1 Media Supplement (Sigma Aldrich) was added.
RNA Extraction, Reverse Transcription and PCR Analysis RNA was extracted from cells using the Direct-zol RNA MiniPrep kit (Zymo Research, Irvine, CA). All steps were done according to the manufacturer's recommended instructions.
RNA samples were quantified and tested for purity using a NanoDrop 2000 machine (Thermo Scientific). cDNA was synthesized from 500 ng of total RNA template using the iScript cDNA synthesis kit (Bio-Rad). Reactions occurred in a T100 Thermal Cycler (Bio-Rad, Hercules, CA) according to the manufacturer's recommended instructions. Quantitative Real Time PCR analysis was performed using CFX Connect Real-Time PCR Detection System (Bio-Rad) and CFX Manager Software (Bio-Rad). Each sample was done in duplicate. Forward and Reverse primers (Table 2) were used at a final concentration of 400 nM with 1 uL cDNA sample, 7.4 uL of DEPC water (GeneMate) and 10 uL of iTaq Universal SYBR Green Supermix (Bio-Rad).
Samples were normalized using the Beta-Actin gene. Following the washes, samples were blocked with PBS with 0.5% TWEEN and 10% Normal Donkey Serum (EMD Millipore Darmstadt, Germany). Cells were blocked for one hour prior to the addition of primary antibody. The primary antibodies were diluted in the block solution.
Cells were incubated in the primary antibody overnight at 4°C in the dark. The primary antibody (Table 3) was aspirated off and cells underwent three washes as described above. Secondary antibody (Santa Cruz Biotech, Santa Cruz, CA) was added at a 1:500 dilution in the block solution. Secondary antibodies covered the cells for one hour at 4°C in the dark. The secondary solution was aspirated and cells were washed three times as described above. Finally, DAPI (Enzo Life Sciences Farmingdale, NY) was added to the cells for 30 seconds before removal and additional washes. Samples were mounted on glass slides (VWR, Radnor, PA) using Fluoromount-G (Electron Microscopy Science, Hartfield PA). 
Addition of Methylglyoxal to Neural Cells
Upon maturation of neural retinal cells, around four months, the cells were treated with one of two conditions. The first condition is a control group, in which media is changed with the traditional NSC media daily. In the second group, the cells were treated with 1.2 mM Methylglyoxal (MG) added to the NSC media. This dose was identified following dose-response cytotoxicity analysis (data not included). Cells were allowed to grow for 24 hours after MG addition. After 24 hours, cells were collected for PCR analysis and immunocytochemistry.
Results
Formation of iPS cells from Lymphocyte Cultures
Following electroporation, a small subset of lymphocytes began to show morphology similar to that of an undifferentiated human stem cell approximately 2 weeks following start of reprogramming (Figure 2, A) . Each undifferentiated looking colony was manually isolated and grown as an independent clone. The best clones were selected and directly compared to H1 undifferentiated ( Figure 2B ) human stem cells. There was no difference in cell morphology between the H1 stem cell colonies and the undifferentiated colonies of the iPS cells resulting from lymphocyte reprogramming ( Figure 2C ). In order to compare the differentiation results using the new ISLI protocol with the established method of using recombinant proteins, we analyzed the cells under identical differentiation conditions. One subset of iPS cells were differentiated using ISLI, while another was differentiated using DKK1, IGF1, and Noggin (DIN). RNA was collected after two weeks of differentiation and genes associated with retinal differentiation were analyzed by RT-PCR ( Figure 6 ). We see a major increase in the expression of the EFTFs, as well as a marked decrease in OCT4, which is a marker of pluripotency ( Figure 6 ). Notable, LHX2 goes from a 14 fold increase to a 50 fold increase, compared to the undifferentiated cells. PAX6 goes from a 229 fold increase to a 1077 fold increase. Additionally, RX goes increases from a 51 fold increase to a 519 fold increase when using ISLI compared to DIN. These drastic changes indicate the small molecules are more efficient at differentiating the stem cells into retinal progenitor cells. 
Establishment of Floating Cultures
The neural regions of the differentiated cells were manually separated from the heterogeneous culture. Neural cell colonies took up a near spherical shape within hours after being grown in the ultra-low attachment plates. Circular growths appeared on these clusters, indicating the development of self-organized optic cups ( Figure 9A ). At 4 weeks after suspension culture, these clusters were sectioned and analyzed via immunocytochemistry. Cells along the outer rim of the cluster were positive for photoreceptor markers Aipl1, Recoverin, NRL and Ret-P1 ( Figure 9B ). Additionally, Sox2, a neural stem cell marker, was only evident in the inner sections of the cluster, indicating a self-organized, layered structure. 
Diabetic Retinopathy
The inherent inability to accurately model age related diseases such as AMD and RP causes many problems when it comes to analyzing the evolution of the diseases. Any human photoreceptors developed from stem cells in vitro would take a similar amount of time to degenerate as they would in vivo. This would require decades of cell maintenance in order to observe the effects of the diseases, which is simply impractical. Therefore, it is important to develop methods to mimic the cellular environment that causes degenerations. Oxidative stress is believed to have a component in the retinal diseases, so we investigated another retinal degenerative disease, RP, in which oxidative stress has more of a well-defined role.
As stated above, one of the major metabolites to accumulate in tissues during diabetes is Once the lymphocytes are reprogrammed into a pluripotent state, they essentially revert to an embryonic state. Photoreceptors that differentiate through the above protocols are young, and are not yet degenerating. We can follow these cells and monitor gene expression levels, among other indications of cell stress, to determine the age and mechanism of degeneration. Artificial stressors can be added to mimic the environment in the eye. While these diseases often take decades to progress in vivo, this process can be greatly accelerated in vitro.
The findings that treatment of neural cells with Methylglyoxal caused a decrease in cell division and increases apoptosis is expected, yet it offers a possible new approach to study diabetic retinopathy. While the mechanism of disease progression is not yet well understood, accumulation of oxidative stress and advanced glycation end products (AGEs) that results in photoreceptor death is a plausible route. Through findings such as decrease in pH3 levels, revealing a decrease in proliferation, decreased and fragmented TUJ expression and an increase in apoptosis; it is clear that the addition of MG is having a negative effect on the photoreceptors.
However, it is unknown whether this mirrors the progression of DR in vivo. Additionally, further testing is required to observe the long-term impact of a low dose of MG, mirroring chronic oxidative stress.
Taken together, the DR data can be approached in a similar fashion to retinal diseases such as AMD and RP. The replacement of photoreceptors damaged as a result of the progression of these diseases is going to be a critical component of restoring vision. Additionally, creating these photoreceptors through iPS cell lines holds several distinct advantages, including the opportunity to use the iPS lines to study disease progression. More research is required to pinpoint the specific degenerations caused by these diseases in an effort to prevent photoreceptor deterioration. However, we have made a significant step by generating a method that allows for the generation of a large number of photoreceptors. The protocol outlined here provides a cheaper, and faster method of differentiating these mature photoreceptors from ES and iPS human cell lines.
Minimizing the amount of time and money required to develop a source of mature photoreceptor cells has many benefits. In addition to a renewable source of cells for transplantation, creating three dimensional structures can be a valuable tool for further research.
These models can help to discover the progression of the disease, as well as provide a more reliable method for drug screening. The ability to more closely model the eye in vivo can help find targeted drugs to combat these age-related degenerative diseases.
